Chicago Illinois | U.S.A.
| Investor Type | Firm |
| Type of Fund | VC |
| Industries | BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • Life Science • Consumer |
| Stages | Series A, Series B, Seed |
| Investing | United States |
| Investment Range | $10,000,000 - $15,000,000 |
| Investment Sweet Spot | $10,000,000 |
| Assets Under Management | $250,000,000 |
About The Fund
Arboretum Ventures is a venture capital firm headquartered in Ann Arbor, Michigan, that specializes in investments across various sectors within the healthcare industry. The firm takes a keen interest in medical devices, medical diagnostics, healthcare technology, healthcare services, and life sciences. With assets under management totaling $250 million, Arboretum Ventures focuses on early-stage funding, providing capital primarily through Series A, Series B, and Seed financing rounds. They target investments ranging from a minimum of $100,000 to a maximum of $5,000,000, with a sweet spot around $1,500,000 for individual funding rounds. The firm identifies itself as a Midwest Healthcare Venture Capital Firm and has cultivated a reputation for venturing the path less traveled by investing in under-ventured geographies and sectors. They prioritize investments in innovations that address significant healthcare problems, enabling transformational impacts and emphasizing capital efficiency for value creation. Arboretum Ventures further underscores the importance of diverse teams, including diversity in thought, geography, and demographics. They take pride in their transformative approach to investing, which has led to a portfolio dominated by investments in under-serviced markets, and over 20 years, they have managed six funds amounting to over $1 billion. Arboretum Ventures leverages a strategy of supportive partnership with their portfolio companies and values deep relationships with entrepreneurs, executives, and investment partners. They also boast of having 45% of all active companies with a female or minority CEO or founder. The firm’s investments have collectively impacted the lives of 16 million patients. Arboretum Ventures seeks to shift the venture capital paradigm by operating with transparency, integrity, and approachability, with a mission to positively impact patients, communities, and healthcare. Their portfolio includes companies like NeuMoDx, which has been acquired by QIAGEN, and other initiatives that span a range of segments from medical devices to life science tools & diagnostics to tech-enabled care delivery and pharma adjacencies.
Arboretum Ventures's investments on record
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
e
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 85 Great Portland St.
- London, U.K.
- contact@angelspartners.com
